Drugs / HZ/su
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06890416 | Apr → Sep 2025 | respiratory syncytial virus infectious disease | Pfizer | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HZ/su | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06890416 ↗ |
| Modality | Vaccine | “HERPES ZOSTER SUBUNIT VACCINE” NCT06890416 ↗ |
| Route | Intramuscular | “intramuscular injection” NCT06890416 ↗ |